AstraZeneca proposes FDA review of all drug ads (Reuters)


Reuters - AstraZeneca Plc on Tuesday proposed a
mandatory requirement for pharmaceutical companies to submit
all direct-to-consumer advertising to the U.S. Food and Drug
Administration for review prior to its use.